Literature DB >> 20510217

Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium.

George Thanassoulis1, Joseph M Massaro, Ricardo Cury, Emily Manders, Emelia J Benjamin, Ramachandran S Vasan, L Adrienne Cupple, Udo Hoffmann, Christopher J O'Donnell, Sekar Kathiresan.   

Abstract

OBJECTIVES: To determine the association of long-term exposure to atherosclerosis risk factors with valvular calcification.
BACKGROUND: Traditional atherosclerosis risk factors have been associated with aortic and mitral valve calcium in cross-sectional studies, but long-term prospective data are lacking.
METHODS: This was a prospective, community-based cohort study with 27-year follow-up (median follow-up 26.9 years; range 23.1 to 29.6 years). Participants from the Framingham Offspring Study (n = 1,323, enrolled between 1971 and 1975, mean age at enrollment 34 +/- 9 years; 52% women) underwent cardiac multidetector computed tomography assessment between 2002 and 2005. Associations between the long-term average of each cardiovascular risk factor and valve calcium were estimated using logistic regression.
RESULTS: Aortic valve calcium was present in 39% of participants and mitral valve calcium in 20%. In multivariable models, the odds ratio for aortic valve calcium associated with every SD increment in long-term mean total cholesterol was 1.74 (p < 0.0001); with every SD increment in high-density lipoprotein cholesterol, it was 0.77 (p = 0.002); and with every 9 cigarettes smoked per day, it was 1.23 (p = 0.002). Associations of similar magnitude were seen for mitral valve calcium. The mean of 3 serum C-reactive protein measurements was associated with mitral valve calcium (odds ratio: 1.29 per SD increment in C-reactive protein levels; p = 0.002). A higher Framingham risk score in early adulthood (40 years age or younger) was associated with increased prevalence and severity of aortic valve calcium measured 3 decades later.
CONCLUSIONS: Exposure to multiple atherosclerotic risk factors starting in early to mid-adulthood is associated with aortic and mitral valve calcium. Studies evaluating early risk factor modification to reduce the burden of valve disease are warranted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510217      PMCID: PMC3042249          DOI: 10.1016/j.jacc.2010.03.019

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  43 in total

1.  Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons.

Authors:  W S Aronow; C Ahn; I Kronzon; M E Goldman
Journal:  Am J Cardiol       Date:  2001-09-15       Impact factor: 2.778

2.  Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve.

Authors:  Marcel Peltier; Faouzi Trojette; Maurice Enriquez Sarano; Francesco Grigioni; Michel A Slama; Christophe M Tribouilloy
Journal:  Am J Cardiol       Date:  2003-01-01       Impact factor: 2.778

3.  The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening.

Authors:  John E Cosmi; Smadar Kort; Paul A Tunick; Barry P Rosenzweig; Robin S Freedberg; Edward S Katz; Robert M Applebaum; Itzhak Kronzon
Journal:  Arch Intern Med       Date:  2002-11-11

4.  Bone formation and inflammation in cardiac valves.

Authors:  E R Mohler; F Gannon; C Reynolds; R Zimmerman; M G Keane; F S Kaplan
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

5.  Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient mice.

Authors:  Yasuharu Matsumoto; Volker Adams; Saskia Jacob; Norman Mangner; Gerhard Schuler; Axel Linke
Journal:  Circulation       Date:  2010-02-01       Impact factor: 29.690

Review 6.  Is aortic stenosis a preventable disease?

Authors:  Kwan-Leung Chan
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

7.  Clinical characteristics of patients younger than 60 years with mitral anular calcium: comparison with age- and sex-matched control subjects.

Authors:  C K Nair; C Sudhakaran; W S Aronow; W Thomson; M P Woodruff; M H Sketch
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778

8.  Prevalence of submitral (anular) calcium and its correlates in a general population-based sample (the Framingham Study).

Authors:  D D Savage; R J Garrison; W P Castelli; P M McNamara; S J Anderson; W B Kannel; M Feinleib
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

9.  An investigation of coronary heart disease in families. The Framingham offspring study.

Authors:  W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

10.  Experimental atherosclerosis of the heart valves in rats following a long-term atherogenic regimen.

Authors:  Z Záhor; V Czabanová
Journal:  Atherosclerosis       Date:  1977-05       Impact factor: 5.162

View more
  24 in total

1.  QCT Volumetric Bone Mineral Density and Vascular and Valvular Calcification: The Framingham Study.

Authors:  Jimmy J Chan; L Adrienne Cupples; Douglas P Kiel; Christopher J O'Donnell; Udo Hoffmann; Elizabeth J Samelson
Journal:  J Bone Miner Res       Date:  2015-05-06       Impact factor: 6.741

2.  Association of Triglyceride-Related Genetic Variants With Mitral Annular Calcification.

Authors:  Mehdi Afshar; Kevin Luk; Ron Do; Line Dufresne; David S Owens; Tamara B Harris; Gina M Peloso; Kathleen F Kerr; Quenna Wong; Albert V Smith; Mathew J Budoff; Jerome I Rotter; L Adrienne Cupples; Stephen S Rich; James C Engert; Vilmundur Gudnason; Christopher J O'Donnell; Wendy S Post; George Thanassoulis
Journal:  J Am Coll Cardiol       Date:  2017-06-20       Impact factor: 24.094

3.  Observational and Genetic Associations of Resting Heart Rate With Aortic Valve Calcium.

Authors:  Seamus P Whelton; Andreas C Mauer; Karol M Pencina; Joseph M Massaro; Ralph B D'Agostino; Caroline S Fox; Udo Hoffmann; Erin D Michos; Gina M Peloso; Line Dufresne; James C Engert; Sekar Kathiresan; Matthew Budoff; Wendy S Post; George Thanassoulis; Christopher J O'Donnell
Journal:  Am J Cardiol       Date:  2018-02-13       Impact factor: 2.778

4.  Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.

Authors:  Amit Pursnani; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; Udo Hoffmann
Journal:  JAMA       Date:  2015-07-14       Impact factor: 56.272

5.  Guideline-Based Statin Eligibility, Cancer Events, and Noncardiovascular Mortality in the Framingham Heart Study.

Authors:  Amit Pursnani; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; Udo Hoffmann
Journal:  J Clin Oncol       Date:  2017-07-12       Impact factor: 44.544

6.  Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis.

Authors:  J Gustav Smith; Kevin Luk; Christina-Alexandra Schulz; James C Engert; Ron Do; George Hindy; Gull Rukh; Line Dufresne; Peter Almgren; David S Owens; Tamara B Harris; Gina M Peloso; Kathleen F Kerr; Quenna Wong; Albert V Smith; Matthew J Budoff; Jerome I Rotter; L Adrienne Cupples; Stephen Rich; Sekar Kathiresan; Marju Orho-Melander; Vilmundur Gudnason; Christopher J O'Donnell; Wendy S Post; George Thanassoulis
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

7.  The association between aortic valve calcification, cardiovascular risk factors, and cardiac size and function in a general population.

Authors:  Lida Khurrami; Jacob Eifer Møller; Jordi Sanchez Dahl; Rasmus Carter-Storch; Nicolaj Lyhne Christensen; Manan Pareek; Jes Sanddal Lindholt; Axel Cosmus Pyndt Diederichsen
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-11       Impact factor: 2.357

Review 8.  Risk factors for valvular calcification.

Authors:  Hao Yu Chen; James C Engert; George Thanassoulis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-04       Impact factor: 3.243

Review 9.  Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis.

Authors:  George Thanassoulis
Journal:  J Lipid Res       Date:  2015-12-18       Impact factor: 5.922

10.  Genetic associations with valvular calcification and aortic stenosis.

Authors:  George Thanassoulis; Catherine Y Campbell; David S Owens; J Gustav Smith; Albert V Smith; Gina M Peloso; Kathleen F Kerr; Sonali Pechlivanis; Matthew J Budoff; Tamara B Harris; Rajeev Malhotra; Kevin D O'Brien; Pia R Kamstrup; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Matthew A Allison; Thor Aspelund; Michael H Criqui; Susan R Heckbert; Shih-Jen Hwang; Yongmei Liu; Marketa Sjogren; Jesper van der Pals; Hagen Kälsch; Thomas W Mühleisen; Markus M Nöthen; L Adrienne Cupples; Muriel Caslake; Emanuele Di Angelantonio; John Danesh; Jerome I Rotter; Sigurdur Sigurdsson; Quenna Wong; Raimund Erbel; Sekar Kathiresan; Olle Melander; Vilmundur Gudnason; Christopher J O'Donnell; Wendy S Post
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.